D. Hart

发表

CALCITONIN AND POSTMENOPAUSAL OSTEOPOROSIS

C. Fletcher, W. Mcintosh, J. Leggate, 1984, Clinical endocrinology.

The effects of hormone implants on serum lipoproteins and steroid hormones in bilaterally oophorectomised women.

C. Fletcher, E. Farish, D. Hart, 1984, Acta endocrinologica.

Lipoprotein and apolipoprotein levels in postmenopausal women on continuous oestrogen/ progestogen therapy

C. Fletcher, F. al-Azzawi, D. Parkin, 1989, British journal of obstetrics and gynaecology.

LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN EVIDENCE FOR AN INCREASED BONE MASS AFTER DELAYED ONSET OF ŒSTROGEN TREATMENT

R. Lindsay, J. M. Aitken, D. Hart, 1976, The Lancet.

The role of megestrol acetate as an alternative to conventional hormone replacement therapy

C. Fletcher, E. Farish, D. Hart, 2000, Climacteric : the journal of the International Menopause Society.

Effects on climacteric symptoms, bone and lipoprotein metabolism of hormone replacement therapy delivered by estradiol-releasing intravaginal rings: a pilot study

E. Farish, D. Hart, J. Barnes, 2003, Climacteric : the journal of the International Menopause Society.

Effects of bilateral oophorectomy on lipoprotein metabolism

C. Fletcher, M. L. Smith, E. Farish, 1990, British journal of obstetrics and gynaecology.

Effects of tibolone on lipoprotein(a) and HDL subfractions.

C. Fletcher, E. Farish, D. Hart, 1994, Maturitas.

EFFECTS OF TREATMENT WITH OESTRADIOL/LEVONORGESTREL ON BONE, LIPOPROTEINS AND HORMONE STATUS IN POSTMENOPAUSAL WOMEN

R. Lindsay, C. Fletcher, G. Beastall, 1989 .

Effect on lipoproteins of Trisequens, a combined hormone preparation.

C. Fletcher, J. Leggate, E. Farish, 1984, Maturitas.

Lipoprotein levels during hormone replacement therapy by vaginal ring pessaries

R. Lindsay, C. Fletcher, E. Farish, 1984, British journal of obstetrics and gynaecology.

Org OD 14: long-term effects on serum lipoproteins.

R. Lindsay, C. Fletcher, J. Leggate, 1984, Maturitas.

Ten years post-menopausal hormone replacement therapy--effect on lipoproteins.

C. Fletcher, C. Howie, E. Farish, 1984, Maturitas.

A long-term study of the effects of norethisterone on lipoprotein metabolism in menopausal women.

C. Fletcher, E. Farish, D. Hart, 1983, Clinica chimica acta; international journal of clinical chemistry.

Long term effect of oestrogen replacement therapy on bone mass as measured by dual photon absorptiometry.

R. Lindsay, F. al-Azzawi, D. Hart, 1987, British medical journal.

Long-Term Effects of Continuous Combined HRT on Bone Turnover and Lipid Metabolism in Postmenopausal Women

C. Fletcher, E. Farish, D. Hart, 1998, Osteoporosis International.

BONE RESPONSE TO TERMINATION OF ŒSTROGEN TREATMENT

R. Lindsay, A. Clark, D. Hart, 1978, The Lancet.

BONE RESPONSE TO TERMINATION OF OESTROGEN TREATMENT

R. Lindsay, A. Clark, D. Hart, 1978 .

Org OD 14 and the endometrium.

D. Hart, A. Genazzani, L. J. Benedek-Jaszmann, 1991, Maturitas.

Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis.

R. Lindsay, D. Hart, A. Kraszewski, 1980, British medical journal.

Effects of long-term Org OD 14 administration on blood coagulation in climacteric women.

R. Lindsay, D. Parkin, D. Smith, 1987, Maturitas.

Oestrogen Replacement Therapy for Prevention of Osteoporosis after Oophorectomy

R. Lindsay, J. M. Aitken, D. Hart, 1973, British medical journal.

Effect of long term hormone replacement on plasma prolactin concentrations in women after oophorectomy.

R. Lindsay, D. Barlow, G. Beastall, 1985, British medical journal.

The effects of conjugated equine oestrogens with and without a cyclical progestogen on lipoproteins, and HDL subfractions in postmenopausal women.

C. Fletcher, C. Howie, E. Farish, 1986, Acta endocrinologica.

Lipoprotein and apoprotein levels in postmenopausal women during treatment with norethisterone.

C. Fletcher, D. Parkin, E. Farish, 1986, Clinica chimica acta; international journal of clinical chemistry.

Lipoprotein (a) concentrations in postmenopausal women taking norethisterone.

J. F. Barnes, E. Farish, D. Hart, 1991, BMJ.

Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions.

C. Fletcher, E. Farish, D. Hart, 1996, Atherosclerosis.

Short-term changes in lipoproteins and apoproteins during cyclical oestrogen-progestogen replacement therapy.

C. Fletcher, E. Farish, D. Hart, 1991, Maturitas.

The effects of conjugated equine estrogens plus cyclical dydrogesterone on serum lipoproteins and apoproteins in postmenopausal women.

C. Fletcher, E. Farish, D. Hart, 1988, Acta endocrinologica.

A comparison of the effects of lipoproteins of two progestogens used during cyclical hormone replacement therapy.

C. Fletcher, E. Farish, D. Hart, 1987, Maturitas.

Lipoprotein(a) and postmenopausal oestrogen.

C. Fletcher, E. Farish, D. Hart, 1993, Acta endocrinologica.

Response of plasma low density lipoprotein subfractions to oestrogen replacement therapy following surgical menopause

B. Griffin, M. Caslake, J. Shepherd, 1993, Clinical endocrinology.

Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women.

R. Lindsay, M. Ferguson, D. Purdie, 1978, Clinical science and molecular medicine.

Oral Complaints Related to Climacteric Symptoms in Oöphorectomized Women 1

R. Lindsay, M. Ferguson, D. Hart, 1981, Journal of the Royal Society of Medicine.

Osteoporosis after Oophorectomy for Non-malignant Disease in Premenopausal Women

R. Lindsay, J. Anderson, J. M. Aitken, 1973, British medical journal.

The effects of oophorectomy and long-term mestranol therapy on the serum lipids of middle-aged women.

T. Lawrie, J. M. Aitken, D. Smith, 1971, Clinical science.

Bone loss during oestriol therapy in postmenopausal women.

R. Lindsay, A. Clark, D. Hart, 1979, Maturitas.

Effects of conjugated equine oestrogens with and without the addition of cyclical norgestrel on serum and urine electrolytes, and the biochemical indices of bone metabolism and liver function.

B. F. Allam, C. Fletcher, E. Farish, 1988, Maturitas.

Effect of subdermal oestrogen and oestrogen/testosterone implants on calcium and phosphorus homeostasis after oophorectomy.

S. Ralston, D. Barlow, C. Fletcher, 1984, Maturitas.

Effect of etidronate disodium on bone turnover following surgical menopause

J. Bevan, I. Fogelman, D. Hart, 1989, Calcified Tissue International.

BONE MASS AFTER WITHDRAWAL OF OESTROGEN REPLACEMENT

R. Lindsay, I. Fogelman, D. Hart, 1981, The Lancet.

Treatment of the premenstrual syndrome: A double blind placebo controlled cross over study using danazol

D. Gilmore, D. Hart, R. Hawthorn, 1989 .

Letters to the EditorOSTEOPOROSIS

R. Lindsay, J. G. Evans, D. Hart, 1976 .

THE EFFECT OF ENDOGENOUS OESTROGEN ON PLASMA AND URINARY CALCIUM AND PHOSPHATE IN OOPHORECTOMIZED WOMEN

R. Lindsay, D. Hart, J. Coutts, 1977, Clinical endocrinology.

The redistribution of body sodium in women on long-term oestrogen therapy.

R. Lindsay, J. M. Aitken, D. Hart, 1974, Clinical science and molecular medicine.

Endogenous oestrogen and bone loss following oophorectomy

R. Lindsay, D. Hart, A. Clarke, 1976, Calcified Tissue Research.

The effect of long-term mestranol administration on calcium and phosphorus homeostasis in oophorectomized women.

J. M. Aitken, D. Smith, D. Hart, 1971, Clinical science.

A study of the experience of Glasgow women in the climacteric years

K. Grosset, D. Barlow, D. Hart, 1989, British journal of obstetrics and gynaecology.

A study of the experience of Glasgow women in the climacteric years

K. Grosset, D. Barlow, D. Hart, 1989, British journal of obstetrics and gynaecology.

Oestrogens and Post-Menopausal Bone Loss

R. Lindsay, D. Hart, 1978, Scottish medical journal.

The endometrial status of women on longterm continuous combined hormone replacement therapy

D. Hart, D. Hart, R. Hawthorn, 1991, British journal of obstetrics and gynaecology.

Long-term oestrogens for the prevention of post-menopausal osteoporosis.

R. Lindsay, J. M. Aitken, D. Hart, 1976, Postgraduate medical journal.

The placental transfer of propylthiouracil, methimazole and carbimazole.

W. Alexander, P. Horton, D. Hart, 1977, The Journal of clinical endocrinology and metabolism.

Sex steroid replacement in post-menopausal women: effects on thyroid hormone status.

G. Beastall, J. Hawthorn, D. Hart, 1987, Maturitas.

Reduced serum free thyroxine concentration in postmenopausal women receiving oestrogen treatment.

G. Beastall, D. Hart, H. I. Abdalla, 1984, British medical journal.

Evaluation of several enzyme tests in vaginal fluid as aids to the diagnosis of invasive and preinvasive cervical cancer.

D. Goldberg, D. Hart, C. Watts, 1970, American journal of obstetrics and gynecology.

Effect of radium treatment on the enzyme content of vaginal fluid in cervical cancer.

D. Goldberg, D. Hart, C. Watts, 1969, American journal of obstetrics and gynecology.

THE RELATIONSHIP BETWEEN MENOPAUSAL VASOMOTOR SYMPTOMS AND GONADOTROPHIN EXCRETION IN URINE AFTER OOPHORECTOMY

R. Lindsay, J. M. Aitken, D. Hart, 1974 .

Hormonal treatments of sexual unresponsiveness in postmenopausal women: a comparative study

M. Dow, D. Hart, C. Forrest, 1983, British journal of obstetrics and gynaecology.

Effects of nadolol on arrhythmias during laparoscopy performed under general anaesthesia.

R. Hughes, W. Hillis, J. Burns, 1988, British journal of anaesthesia.

HYPERCORTISOLAEMIA AND LACK OF SKELETAL RESPONSE TO OESTROGEN IN POSTMENOPAUSAL WOMEN

R. Lindsay, J. M. Aitken, D. Hart, 1974, Clinical endocrinology.

PREVENTION OF SPINAL OSTEOPOROSIS IN OOPHORECTOMISED WOMEN

R. Lindsay, R. Lindsay, D. M. Hart, 1980, The Lancet.

SKELETAL UPTAKE OF DIPHOSPHONATE Method for Prediction of Post-menopausal Osteoporosis

R. Lindsay, I. Fogelman, R. Bessent, 1980, The Lancet.

Organon OD 14 (tibolone) and menopausal dynamic hormone profiles.

R. Lindsay, G. Beastall, D. Hart, 1986, Maturitas.

Assessment of synthetic steroid (Org OD 14): effect on skeletal metabolism by 24-h whole-body retention of diphosphonate.

R. Lindsay, I. Fogelman, R. Bessent, 1981, Maturitas.

Long-Term Hormone Implant Therapy—Hormonal and Clinical Effects

D. Barlow, D. Hart, F. A. Azzawi, 1986, Obstetrics and gynecology.

The Minimum Effective Dose of Estrogen for Prevention of Postmenopausal Bone Loss

R. Lindsay, D. Hart, D. M. Clark, 1984, Obstetrics and gynecology.

Management of the patient including the high-risk patient

D. Serr, R. Greenblatt, C. Lauritzen, 1979 .

Plasma zinc in pre- and post-menopausal women: its relationship to oestrogen therapy.

R. Lindsay, J. M. Aitken, D. Hart, 1973, Clinical science.

Failure of response of menopausal vasomotor symptoms to clonidine.

R. Lindsay, D. Hart, 1978, Maturitas.

The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women.

J. Petrie, M. Lumsden, H. Lyall, 1999, The Journal of clinical endocrinology and metabolism.

Long-term Follow-up of Women on HRT

D. Hart, 1990 .

Blood coagulation profile in long-term hormone replacement therapy with mestranol.

R. Lindsay, F. al-Azzawi, D. Parkin, 1989, Maturitas.

Differential effect of long-term oestrogen therapy on trabecular and cortical bone.

F. al-Azzawi, D. Hart, C. Hosie, 1989, Maturitas.

Investigation of the bleeding patterns of postmenopausal women treated with Estrapak-50.

F. al-Azzawi, D. Hart, J. Hawley, 1994, Maturitas.

Reversible menopause induced by the GnRH analogue buserelin: effects on lipoprotein metabolism.

C. Fletcher, E. Farish, D. Hart, 1992, Acta endocrinologica.

The effect of ovarian sex steroids on bone mineral status in the oöphorectomized rat and in the human.

R. Lindsay, J. M. Aitken, D. Purdie, 1978, Postgraduate medical journal.

Effects of tibolone on serum lipoprotein and apolipoprotein levels compared with a cyclical estrogen/progestogen regimen.

C. Fletcher, E. Farish, D. Hart, 1999, Menopause.

Prevention of bone loss following oophorectomy in premenopausal women: a retrospective assessment of the effects of oophorectomy and a prospective controlled trial of the effects of mestranol therapy.

R. Lindsay, J. Anderson, J. M. Aitken, 1976, Israel journal of medical sciences.

Electrophysiology of the oviduct.

G. Dimitrov, D. Nance, R. Gorski, 1976 .

THE EFFECT OF OESTROGEN (MESTRANOL) ON THE THYROTROPHIN RESPONSE TO THYROTROPHIN RELEASING HORMONE IN POSTMENOPAUSAL OOPHORECTOMISED WOMEN

D. Hart, H. I. Abdalla, G. H. BEASTALL, 1984, Clinical endocrinology.

Minimum effective dose of estrogen for protection against post menopausal bone loss

R. Lindsay, I. Fogelman, D. Hart, 1982 .

Changes in the bone and liver isoenzymes of alkaline phosphatase in postmenopausal women being treated with norethisterone

C. Fletcher, E. Farish, D. Hart, 1988 .

Danol for Premenstrual Syndrome: A Preliminary Report of a Placebo-Controlled Double-Blind Study

D. Gilmore, D. Hart, R. Hawthorn, 1985, The Journal of international medical research.

Evaluation of a psychological treatment programme for climacteric women.

J. Greene, D. Hart, 1987, Maturitas.